US$ 21.14
glp-1 prescriptions growth slowdown 2024 Novo cuts prices 70%, but semaglutide revenue could grow in 2026 GLP-1 Receptor Agonist Market Growth
Description
While the lawyer evaluates your case, youre also determining if theyre the right fit for you

In 2021, China had 141 million people with diabetes, projected to rise to 164 million by 2030 the highest globally, according to the International Diabetes Federation

However, developing drugs that can effectively target all three aspects has proven challenging

Diabetologia 36 , 857862 (1993)

Every step increases by exactly 2.5 mg
